STOCK TITAN
  1. Home
  2. Sec-filings
  3. RAPP
  4. [EFFECT] Rapport Therapeutics, Inc. SEC Filing

[EFFECT] Rapport Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 4:01 P.M.
Form: S-3
CIK: 0002012593
Company Name: Rapport Therapeutics, Inc.
File Number: 333-288445

Source: View Original Filing on SEC EDGAR

Stock RAPP logo
Rapport Therapeutics Inc

NASDAQ:RAPP

RAPP Rankings

#3203 Ranked by Market Cap
N/A Ranked by Dividends

RAPP Latest News

Aug 13, 2025
Alto Neuroscience Appoints Biotech Industry Veteran, Raymond Sanchez, M.D., to Its Board of Directors
Aug 7, 2025
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update
Jun 2, 2025
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
May 27, 2025
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference
May 21, 2025
Rapport Therapeutics to Host 2025 Investor and Analyst Day

RAPP Latest SEC Filings

Aug 18, 2025
[Form 4] Rapport Therapeutics, Inc. Insider Trading Activity
Aug 7, 2025
[10-Q] Rapport Therapeutics, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] Rapport Therapeutics, Inc. Reports Material Event
Jul 16, 2025
[Form 4] Rapport Therapeutics, Inc. Insider Trading Activity
Jul 10, 2025
[EFFECT] Rapport Therapeutics, Inc. SEC Filing

RAPP Stock Data

548.93M
34.21M
6.26%
106.24%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON